High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors

Beat M. Frey, Neil R. Hackett, Jeffrey M. Bergelson, Robert Finberg, Ronald Crystal, Malcolm A.S. Moore, Shahin Rafii

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Replication-deficient adenoviral vectors (AdVec), which infect cycling and noncycling cells with high efficiency, low toxicity, arid ease of delivery, provide ideal vehicles to study the expression of regulatory genes controlling different stages of hematopoiesis. To examine the infection efficiency of AdVec in hematopoietic precursor and progenitor cells, we used a replication-dependent adenovector expressing the humanized form of the cDNA for green fluorescent protein (AdGFP), permitting assessment of infection efficiency and kinetics of transgene expression in viable hematopoietic cells using flow cytometry and fluorescence microscopy. Flow-cytometric analysis of ex vivo expanded hematopoietic precursor cells infected with a multiplicity of infection (MOI) of 100 of AdGFP show that 78% of megakaryocytic (CD41a+ arid CD42b+) cells, 82% of dendritic (CD1a+) cells, 41% of RBC precursors (glycophorin A+), and 32% of monocytic (CD14+) cells expressed GFP. Nineteen percent ± 1% of freshly isolated CD34+ cells from peripheral blood leukapheresis products infected under the same conditions expressed GFP. Morphologic evaluation of ex vivo expanded, AdGFP-infected CD34+ cells showed normal maturation. The functional capacity of AdGFP-infected CD34+ cells was analyzed by quantifying clonogeneic efficiency and proliferative capacity. Infection of CD34+ progenitor cells with MOIs of 1 to 100 did not impair clonogeneic efficiency of CD34+ cells: However, MOI greater than 100 resulted in a significant inhibition of colony-forming unit- granulocyte/granulocyte-macrophage (CFU-G/GM) formation. In sequential dilution expansion over 3 weeks (Delta assay), the cytokine-driven proliferative potential of CD34+ cells was not impaired following exposure to AdGFP at MOIs of 1 to 1,000. The GFP+ population expended 10- to 15-fold at high MOIs (500 to 1,000), indicating multiple copies of the transgene in the initially infected CD34+ cells, which were expressed in subsequent progenies. These data show that AdVec deliver transgenes with high efficiency and low toxicity to hematopoietic progenitor and precursor cells. Introduction of marker genes such as GFP into hematopoietic cells by AdVec will provide a valuable system for study of development, homing, and trafficking of hematopoietic precursor end progenitor cells in vitro and in vivo. Furthermore, these results provide insights into the design of gene therapy strategies for treatment of hematologic disorders by AdVec.

Original languageEnglish
Pages (from-to)2781-2792
Number of pages12
JournalBlood
Volume91
Issue number8
Publication statusPublished - 15 Apr 1998
Externally publishedYes

Fingerprint

Gene transfer
Hematopoietic Stem Cells
Adenoviridae
Genes
Toxicity
Transgenes
Infection
Glycophorin
Stem Cells
Gene therapy
Flow cytometry
Macrophages
Fluorescence microscopy
Granulocytes
Green Fluorescent Proteins
Dilution
Assays
Blood
Complementary DNA
Leukapheresis

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

Frey, B. M., Hackett, N. R., Bergelson, J. M., Finberg, R., Crystal, R., Moore, M. A. S., & Rafii, S. (1998). High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. Blood, 91(8), 2781-2792.

High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. / Frey, Beat M.; Hackett, Neil R.; Bergelson, Jeffrey M.; Finberg, Robert; Crystal, Ronald; Moore, Malcolm A.S.; Rafii, Shahin.

In: Blood, Vol. 91, No. 8, 15.04.1998, p. 2781-2792.

Research output: Contribution to journalArticle

Frey, BM, Hackett, NR, Bergelson, JM, Finberg, R, Crystal, R, Moore, MAS & Rafii, S 1998, 'High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors', Blood, vol. 91, no. 8, pp. 2781-2792.
Frey BM, Hackett NR, Bergelson JM, Finberg R, Crystal R, Moore MAS et al. High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. Blood. 1998 Apr 15;91(8):2781-2792.
Frey, Beat M. ; Hackett, Neil R. ; Bergelson, Jeffrey M. ; Finberg, Robert ; Crystal, Ronald ; Moore, Malcolm A.S. ; Rafii, Shahin. / High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. In: Blood. 1998 ; Vol. 91, No. 8. pp. 2781-2792.
@article{72e39a591a964272bcea48ab15eb2373,
title = "High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors",
abstract = "Replication-deficient adenoviral vectors (AdVec), which infect cycling and noncycling cells with high efficiency, low toxicity, arid ease of delivery, provide ideal vehicles to study the expression of regulatory genes controlling different stages of hematopoiesis. To examine the infection efficiency of AdVec in hematopoietic precursor and progenitor cells, we used a replication-dependent adenovector expressing the humanized form of the cDNA for green fluorescent protein (AdGFP), permitting assessment of infection efficiency and kinetics of transgene expression in viable hematopoietic cells using flow cytometry and fluorescence microscopy. Flow-cytometric analysis of ex vivo expanded hematopoietic precursor cells infected with a multiplicity of infection (MOI) of 100 of AdGFP show that 78{\%} of megakaryocytic (CD41a+ arid CD42b+) cells, 82{\%} of dendritic (CD1a+) cells, 41{\%} of RBC precursors (glycophorin A+), and 32{\%} of monocytic (CD14+) cells expressed GFP. Nineteen percent ± 1{\%} of freshly isolated CD34+ cells from peripheral blood leukapheresis products infected under the same conditions expressed GFP. Morphologic evaluation of ex vivo expanded, AdGFP-infected CD34+ cells showed normal maturation. The functional capacity of AdGFP-infected CD34+ cells was analyzed by quantifying clonogeneic efficiency and proliferative capacity. Infection of CD34+ progenitor cells with MOIs of 1 to 100 did not impair clonogeneic efficiency of CD34+ cells: However, MOI greater than 100 resulted in a significant inhibition of colony-forming unit- granulocyte/granulocyte-macrophage (CFU-G/GM) formation. In sequential dilution expansion over 3 weeks (Delta assay), the cytokine-driven proliferative potential of CD34+ cells was not impaired following exposure to AdGFP at MOIs of 1 to 1,000. The GFP+ population expended 10- to 15-fold at high MOIs (500 to 1,000), indicating multiple copies of the transgene in the initially infected CD34+ cells, which were expressed in subsequent progenies. These data show that AdVec deliver transgenes with high efficiency and low toxicity to hematopoietic progenitor and precursor cells. Introduction of marker genes such as GFP into hematopoietic cells by AdVec will provide a valuable system for study of development, homing, and trafficking of hematopoietic precursor end progenitor cells in vitro and in vivo. Furthermore, these results provide insights into the design of gene therapy strategies for treatment of hematologic disorders by AdVec.",
author = "Frey, {Beat M.} and Hackett, {Neil R.} and Bergelson, {Jeffrey M.} and Robert Finberg and Ronald Crystal and Moore, {Malcolm A.S.} and Shahin Rafii",
year = "1998",
month = "4",
day = "15",
language = "English",
volume = "91",
pages = "2781--2792",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "8",

}

TY - JOUR

T1 - High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors

AU - Frey, Beat M.

AU - Hackett, Neil R.

AU - Bergelson, Jeffrey M.

AU - Finberg, Robert

AU - Crystal, Ronald

AU - Moore, Malcolm A.S.

AU - Rafii, Shahin

PY - 1998/4/15

Y1 - 1998/4/15

N2 - Replication-deficient adenoviral vectors (AdVec), which infect cycling and noncycling cells with high efficiency, low toxicity, arid ease of delivery, provide ideal vehicles to study the expression of regulatory genes controlling different stages of hematopoiesis. To examine the infection efficiency of AdVec in hematopoietic precursor and progenitor cells, we used a replication-dependent adenovector expressing the humanized form of the cDNA for green fluorescent protein (AdGFP), permitting assessment of infection efficiency and kinetics of transgene expression in viable hematopoietic cells using flow cytometry and fluorescence microscopy. Flow-cytometric analysis of ex vivo expanded hematopoietic precursor cells infected with a multiplicity of infection (MOI) of 100 of AdGFP show that 78% of megakaryocytic (CD41a+ arid CD42b+) cells, 82% of dendritic (CD1a+) cells, 41% of RBC precursors (glycophorin A+), and 32% of monocytic (CD14+) cells expressed GFP. Nineteen percent ± 1% of freshly isolated CD34+ cells from peripheral blood leukapheresis products infected under the same conditions expressed GFP. Morphologic evaluation of ex vivo expanded, AdGFP-infected CD34+ cells showed normal maturation. The functional capacity of AdGFP-infected CD34+ cells was analyzed by quantifying clonogeneic efficiency and proliferative capacity. Infection of CD34+ progenitor cells with MOIs of 1 to 100 did not impair clonogeneic efficiency of CD34+ cells: However, MOI greater than 100 resulted in a significant inhibition of colony-forming unit- granulocyte/granulocyte-macrophage (CFU-G/GM) formation. In sequential dilution expansion over 3 weeks (Delta assay), the cytokine-driven proliferative potential of CD34+ cells was not impaired following exposure to AdGFP at MOIs of 1 to 1,000. The GFP+ population expended 10- to 15-fold at high MOIs (500 to 1,000), indicating multiple copies of the transgene in the initially infected CD34+ cells, which were expressed in subsequent progenies. These data show that AdVec deliver transgenes with high efficiency and low toxicity to hematopoietic progenitor and precursor cells. Introduction of marker genes such as GFP into hematopoietic cells by AdVec will provide a valuable system for study of development, homing, and trafficking of hematopoietic precursor end progenitor cells in vitro and in vivo. Furthermore, these results provide insights into the design of gene therapy strategies for treatment of hematologic disorders by AdVec.

AB - Replication-deficient adenoviral vectors (AdVec), which infect cycling and noncycling cells with high efficiency, low toxicity, arid ease of delivery, provide ideal vehicles to study the expression of regulatory genes controlling different stages of hematopoiesis. To examine the infection efficiency of AdVec in hematopoietic precursor and progenitor cells, we used a replication-dependent adenovector expressing the humanized form of the cDNA for green fluorescent protein (AdGFP), permitting assessment of infection efficiency and kinetics of transgene expression in viable hematopoietic cells using flow cytometry and fluorescence microscopy. Flow-cytometric analysis of ex vivo expanded hematopoietic precursor cells infected with a multiplicity of infection (MOI) of 100 of AdGFP show that 78% of megakaryocytic (CD41a+ arid CD42b+) cells, 82% of dendritic (CD1a+) cells, 41% of RBC precursors (glycophorin A+), and 32% of monocytic (CD14+) cells expressed GFP. Nineteen percent ± 1% of freshly isolated CD34+ cells from peripheral blood leukapheresis products infected under the same conditions expressed GFP. Morphologic evaluation of ex vivo expanded, AdGFP-infected CD34+ cells showed normal maturation. The functional capacity of AdGFP-infected CD34+ cells was analyzed by quantifying clonogeneic efficiency and proliferative capacity. Infection of CD34+ progenitor cells with MOIs of 1 to 100 did not impair clonogeneic efficiency of CD34+ cells: However, MOI greater than 100 resulted in a significant inhibition of colony-forming unit- granulocyte/granulocyte-macrophage (CFU-G/GM) formation. In sequential dilution expansion over 3 weeks (Delta assay), the cytokine-driven proliferative potential of CD34+ cells was not impaired following exposure to AdGFP at MOIs of 1 to 1,000. The GFP+ population expended 10- to 15-fold at high MOIs (500 to 1,000), indicating multiple copies of the transgene in the initially infected CD34+ cells, which were expressed in subsequent progenies. These data show that AdVec deliver transgenes with high efficiency and low toxicity to hematopoietic progenitor and precursor cells. Introduction of marker genes such as GFP into hematopoietic cells by AdVec will provide a valuable system for study of development, homing, and trafficking of hematopoietic precursor end progenitor cells in vitro and in vivo. Furthermore, these results provide insights into the design of gene therapy strategies for treatment of hematologic disorders by AdVec.

UR - http://www.scopus.com/inward/record.url?scp=0032522956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032522956&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 2781

EP - 2792

JO - Blood

JF - Blood

SN - 0006-4971

IS - 8

ER -